Sexually Transmitted Diseases

Skip Navigation LinksHome > July 2011 - Volume 38 - Issue 7 > High Chlamydia and Gonorrhea Incidence and Reinfection Among...
Sexually Transmitted Diseases:
doi: 10.1097/OLQ.0b013e318214e408
Original Study

High Chlamydia and Gonorrhea Incidence and Reinfection Among Performers in the Adult Film Industry

Goldstein, Binh Y. PhD; Steinberg, Jane K. PhD; Aynalem, Getahun MD, MPH; Kerndt, Peter R. MD, MPH

Collapse Box


Background: Adult film industry (AFI) performers engage in unprotected oral, vaginal, and anal sex with multiple partners, increasing the likelihood of acquisition and transmission of human immunodeficiency virus and other sexually transmitted diseases. Current industry practice does not require condom use; instead it relies upon limited testing. We sought to estimate the annual cumulative incidence of chlamydia (CT) and gonorrhea (GC) and assess the rate of reinfection among AFI performers.

Methods: We retrieved all CT and GC cases diagnosed among performers between 2004 and 2008 in Los Angeles, CA and reported to the health department surveillance registry. Using 2008 data, we estimated ranges for CT and GC annual cumulative incidences based on assumptions of the population size of performers. For cases reported between 2004 and 2007, we determined the CT and/or GC reinfection rate within 1 year.

Results: Lower bounds for the annual cumulative incidences of CT and GC among AFI performers were estimated to be 14.3% and 5.1%, respectively. The reinfection rate within 1 year was 26.1%. Female performers were 27% more likely to be reinfected as compared with male performers (prevalence ratio, 1.27; 95% confidence interval, 1.09–1.48).

Conclusion: CT and GC infections are common and recurrent among performers. Control strategies, including promotion of condom use, are needed to protect workers in this industry, as testing alone will not effectively prevent workplace acquisition and transmission. Additional legislation that places more responsibility on the production companies is needed to ensure the safety and health of performers.

© Copyright 2011 American Sexually Transmitted Diseases Association


Article Tools


Article Level Metrics